Furthermore, recent studies implicate the cancer-promoting role of dysregulated CXCL13-CXCR5 chemokine pathway in various hematologic [20–22] and solid malignancies [23–25], while no data are available in MM. This evidence concerns the gene CXCL13 and Miyoshi myopathy.